Share this:

Washington, D.C. – The purpose of recertification for specialty certifications offered by the Board of Pharmacy Specialties (BPS) is to ensure that board-certified pharmacists maintain knowledge and skills required for a specific level of proficiency in the specialty area in which they are certified. BPS complies with the National Commission for Certifying Agencies (NCCA) standards on maintenance of certification. NCCA defines recertification as “requirements and procedures established as part of a certification program that certificants must meet to maintain competence and renew their certification.”

 

Recertification, which is required every 7 years, is a process by which a board-certified pharmacist demonstrates maintenance of a defined level of contemporary knowledge and skills in the respective specialty and attests to current licensure/registration in pharmacy. The level of competency required for a specialty certification program will evolve as that specialty practice and its associated competencies advance and are validated through periodic job analyses to develop the examination content outline for each BPS specialty program. Assessment of contemporary knowledge and skills will be accomplished through one of two recertification pathways

 

Pathway 1: Recertification by professional development program (PDP)

Earn the required number of units of continuing education credit provided by a PDP approved by BPS for the certification which is held. Some specialties have different requirements. Please see the individual website pages for more information.

— OR —

Pathway 2: Recertification by examination

Achieve a passing score on the recertification examination

 

In January 2023, BPS announced an update to recertification pathways to include continuing professional development (CPD) activities. The recertification pathways listed below apply to any pharmacist certified for the first time and/or recertifying in 2023 and beginning a new (initial or subsequent) recertification cycle January 1, 2024. Each yearly cohort of newly certified or recertified pharmacists from 2024 onward will then transition into this new mode until it applies to all board-certified pharmacists in 2030 (more information can be found here.)

 

**Pathway 1: Recertification by professional development program (PDP)

Successfully complete a total of 100 units, comprised of: 80 units of BPS-approved, assessed CPE (up to 40 of the 80 units may be claimed to meet the requirements of two or more certifications) AND 20 units of self-selected/self-reported CPD activities

— OR —

**Pathway 2: Recertification by examination

Achieve a passing score on the recertification examination AND complete a total of 20 units of self-selected/self-reported CPD activities

 

In April 2022, BPS issued a request for proposals to provide professional development programs for the recertification of board-certified pharmacists beginning in 2024. Interested entities submitted a proposal in August 2022 and the BPS Specialty Councils and Board of Directors concluded their review of proposals from PDP providers in November 2022. BPS is pleased to announce the approval of the following PDP providers for the contract period beginning January 1, 2024 through December 31, 2030:

 

Ambulatory Care Pharmacy

The American College of Clinical Pharmacy (ACCP) in collaboration with the American Society of Health-System Pharmacists (ASHP)

 

Cardiology Pharmacy

The American College of Clinical Pharmacy (ACCP) in collaboration with the American Society of Health-System Pharmacists (ASHP)

 

Compounded Sterile Preparations Pharmacy

The American Pharmacists Association (APhA)

The American Society of Health-System Pharmacists (ASHP)

 

Critical Care Pharmacy

The American College of Clinical Pharmacy (ACCP) in collaboration with the American Society of Health-System Pharmacists (ASHP)

 

Emergency Medicine Pharmacy

The American Society of Health-System Pharmacists (ASHP) in collaboration with the American College of Clinical Pharmacy (ACCP)

 

Geriatric Pharmacy

The American Society of Consultant Pharmacists (ASCP) in collaboration with the American Pharmacists Association (APhA)

The American Society of Health-System Pharmacists (ASHP) in collaboration with the American College of Clinical Pharmacy (ACCP)

Tabula Rasa HealthCare University

 

Infectious Diseases Pharmacy

The American Society of Health-System Pharmacists (ASHP) in collaboration with the American College of Clinical Pharmacy (ACCP)

The Society of Infectious Diseases Pharmacists (SIDP)

 

Nuclear Pharmacy

Purdue University College of Pharmacy

 

Nutrition Support Pharmacy

Purdue University College of Pharmacy

 

Oncology Pharmacy

The American Society of Health-System Pharmacists (ASHP) in collaboration with the American College of Clinical Pharmacy (ACCP)

The Hematology/Oncology Pharmacy Association (HOPA)

 

Pediatric Pharmacy

The American Society of Health-System Pharmacists (ASHP) in collaboration with the American College of Clinical Pharmacy (ACCP)

The Pediatric Pharmacy Association (PPA)

 

Pharmacotherapy

The American College of Clinical Pharmacy (ACCP)

The American Society of Health-System Pharmacists (ASHP)

 

Psychiatric Pharmacy

The American Association of Psychiatric Pharmacists (AAPP)

 

Solid Organ Transplantation Pharmacy

The American College of Clinical Pharmacy (ACCP) in collaboration with the American Society of Health-System Pharmacists (ASHP)

 

Organizations that were not awarded contracts for the 2024-2030 period may contribute to pharmacist board-certification and recertification in ways other than BPS-approved, assessed continuing education. Such ways may include offering preparatory courses for BPS examinations, offering Accreditation Council for Pharmacy Education (ACPE)-approved continuing education (which may be counted as CPD units), or facilitating CPD activities for board-certified pharmacists.

 

BPS anticipates the next multi-specialty request for proposal will be issued in late 2028 or early 2029. Any organization is welcome to submit a proposal at that time. A request for proposals in a newly BPS-recognized specialty area may be issued in the interim and any organization may submit a proposal in response.

 

For more information on recertification, please review the BPS Recertification Guide. For questions about recertification, please Contact BPS. If you are an organizational representative with questions about the RFP or contract process, please contact Ellie LaNou at elanou@aphanet.org.

 

About the Board of Pharmacy Specialties

The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA). The mission of BPS is to improve patient care by positioning BPS Board-Certified Pharmacist Specialists as integral members of multidisciplinary healthcare teams, through recognition and promotion of specialized training, knowledge, and skills for pharmacists in the United States and internationally. Board certification is a recognized credential for determining which pharmacists are qualified to contribute at advanced practice levels given the rigorous standards mandated by BPS board certification and recertification. BPS has currently issued more than 57,600 certifications held by pharmacists across 14 specialties.

 

BPS Media Contact
Alexander Jean-Baptiste
Senior Manager, Social Media & Content Marketing 
ajeanbaptiste@aphanet.org
(202) 760-3836